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Summary
Lymphedema-distichiasis (LD) is a dominantly inher-
ited syndrome with onset of lymphedema at or just
after puberty. Most affected individuals have disti-
chiasis—fine hairs arising inappropriately from the
eyelid meibomian glands—which is evident from
birth. A study of three families with LD has shown
linkage to chromosome 16q24.3, and subsequent
analysis of the region for recombinant genes places
the locus between D16S422 and D16S3074, a distance
of ∼16 cM. Possible candidate genes in this interval
include the N-proteinase for type 3 collagen,
PCOLN3; the metalloprotease PRSM1; and the cell
matrix–adhesion regulator, CMAR.
Introduction
Primary lymphedema (MIM 153200) is edema that oc-
curs as a consequence of a failure of lymph drainage
and arises from an intrinsic abnormality of the lymphatic
system (Mortimer 1995). The lymph-conducting path-
ways are assumed to be congenitally abnormal, although
lymphedema may not manifest until later in life. Thirty-
five percent of all patients with primary lymphedema
have a positive family history (Dale 1985). Primary lym-
phedema can be present at birth, as in Milroy disease,
but it more commonly has a later onset, developing at
or after puberty, when it is termed “Meige disease”
(Goodman 1962; Wheeler et al. 1981; Herbert and
Bowen 1983). Meige disease represents 80% of lym-
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phedema cases and is thought to be due to gradual oblit-
eration of the peripheral lymphatic system.
A gene for Milroy disease has recently been located
on chromosome 5 by members of our consortium and
others (Ferrell et al. 1998; Evans et al. 1999 [in press]).
The loci responsible for Meige disease have been more
elusive (Hardy et al. 1995). Genetic heterogeneity be-
tween families and establishment of phenotype are the
most likely causes of this failure to locate the loci.
We have therefore chosen to study a specific form of
lymphedema: lymphedema-distichiasis (LD) (MIM
153400). This syndrome, a rare cause of primary lym-
phedema (Robinow et al. 1970; Dale 1987), is associated
with congenital distichiasis (fine hairs arising inappro-
priately from the openings of the meibomian glands on
the inner eyelid), which may cause severe irritation of
the cornea. LD is inherited as an autosomal dominant
disorder with variable expressivity and penetrance (Tem-
ple and Collin 1994). Associated features of LD have
been reviewed by Temple and Collin (1994) and include
congenital heart defects, vertebral anomalies, extradural
cysts, ptosis (Kinmonth et al. 1957), and cleft palate.
Subjects and Methods
Three families with LD were identified by the genetics
and surgical departments of St. George’s and St. Tho-
mas’ Hospitals, London. All studies were performed
with the full informed consent of the patients, and ethical
permission was obtained from the local ethics commit-
tees at St. George’s and St. Thomas’ Hospitals. Individ-
uals within these families were subject to clinical ex-
amination whenever this was practical. Family 3 was
further investigated by use of lymphoscintigraphy in
clinically affected and unaffected family members (J.
Rosbotham et al., unpublished data). Lymphoscintig-
raphy is based on the principle that the essential function
of the lymphatic system is to return to the vascular com-
partment those proteins and colloids that are too large
to reenter directly. The dynamics of lymph flow—as de-
picted by the uptake of technetium-99m rhenium sulfur
colloid, its transit via the lymphatic vessels, and its trap-
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Table 1
Clinical Details for the Members of Families 1 and 2
Family
and
Individual Lymphedema Distichiasis Venous Insufficiencya Congenital Anomaly
Family 1:
1.I.1 Present (history) Recurrent
conjunctivitis Varicose veins






1.II.4 Present Present Atrophic hyperpigmented skin
1.II.5 Present Present Varicose veins, ovarian
varicoceles
Ventricular septal defect, mitral and aortic
regurgitation, sinus bradycardia
1.III.1 Absent Present Absent Synophrys
1.III.2 Present Present Varicose veins Sinus bradycardia
1.III.3 Not examined Not examined Varicose veins Cleft palate
Family 2:
2.I.2 Present (history) Not examined Not examined
2.II.1 Present Present Varicose veins, eczema
2.II.3 Present (history) Present (history) Not examined
2.III.1 Normal Normal Normal
2.III.3 Present (history) Present (history) Not examined Ptosis
2.III.5 Present Present Normal Synophrys, kyphosis
2.IV.1 Mild swelling Present Varicose veins Ptosis
2.IV.2 Normal Present Absent
2.IV.3 Present Present Normal Synophrys, Fallot tetralogy
a Determined by clinical examination.
ping in regional lymph nodes—are studied by use of
either a scintiscanner or a gamma camera with a large
field of view (Stewart et al. 1985).
Because distichiasis is rare, all family members with
definite distichiasis were classified as affected, with or
without lymphedema. In the absence of distichiasis, a
family member was considered to be affected if he or
she had either severe early-onset lymphedema or a pos-
itive result on lymphoscintigraphy plus one of the afore-
mentioned associated anomalies. Venous insufficiency is
so common in the general population that it was not
used as a criterion for diagnosis; however, it was noted
to be present in a high proportion of affected individuals
(J. Rosbotham et al., unpublished data), often with a
premature onset. For example, in family 2, individual
2.IV.1 had varicose veins beginning at 12 years of age
and had an operation to strip the saphenous vein at 16
years of age.
In families 1 and 2, there were two individuals in
whom distichiasis occurred without lymphedema. In-
dividual 2.IV.2 in family 2 was prepubertal (13 years of
age) at the time of this study, but individual 1.III.1 was
19 years of age and showed no sign of limb edema.
Individual 3.III.3 in family 3 could not be examined for
distichiasis, but he was considered to be positive for the
condition according to the other criteria previouslymen-
tioned. He had very severe lymphedema with onset early
in childhood and, in addition, had ptosis, which was
inherited from his father. Ptosis, which has been previ-
ously associated with LD, was identified in three affected
individuals in this study and was reported in another
individual in another study (Kinmonth et al. 1957).
On the basis of our classification, there were three
individuals in family 3 who were difficult to assign:
3.II.8, 3.II.11, and 3.III.5 (fig. 1). Individual 3.II.8 is an
80-year-old man who has mild swelling of the dorsum
of the left foot and abnormal findings on lymphoscin-
tigraphy on the same side. However, he denied having
had lymphedema when younger, had no other associated
anomalies, and, despite his age, had no venous insuffi-
ciency either clinically or on testing with light-reflective
rheography. Although his age and cardiac failure, for
which he was taking digoxin, are likely to explain the
observed abnormalities, we have classified him as being
of unknown status. Individual 3.II.11 had no clinical
manifestations of LD, but she claimed to have had leg
swelling as an adolescent and has, at 30 min, a unilateral
abnormal lymphoscintigraphy result that, by 60 min, is
within normal limits. There is some uncertainty with
regard to the interpretation of lymphoscintigraphy re-
sults on early readings. Protocols vary and some centers
ignore the results at 30 min, placing more emphasis on
later readings (Proby et al. 1990). Mild pitting edema
was evident on examination of individual 3.II.11, but
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Table 2
Clinical Details for the Members of Family 3
Family 3 Lymphedema Distichiasis
Venous
Insufficiencya Lymphosyntigraphy Congenital Anomaly
3.II.1 Normal Normal Normal Normal
3.II.2 Present (history) Not examined Not examined Not performed
3.II.4 Present (history) Not examined Not examined Not performed Ptosis
3.II.6 Present (history) Not examined Not examined Not performed
3.II.8 Mild swelling (no history) Normal Normal Positive (in heart failure)
3.II.10 Present Present Uncertain Positive
3.II.11 Normal Normal Present Positive, normal at 60 min
3.III.1 Normal Normal Present Normal
3.III.2 Normal Normal Normal Normal
3.III.3 Present Normal Uncertain Positive Ptosis
3.III.5 Normal Normal Normal Normal at 60 min
3.III.6 Normal Normal Present Normal
3.III.7 Present Present Uncertain Positive
3.III.9 Present Present Present Positive
3.III.10 Normal Normal Normal Normal
3.III.11 Present Present Present Positive
3.IV.1 Normal Normal Normal Normal
3.IV.2 Normal Normal Normal Normal
3.IV.3 Present Present Present Positive Congenital heart disease
3.IV.4 Normal Present Present Normal
3.IV.5 Normal Not examined Present Normal
a Determined by light-reflective rheography. “Uncertain” indicates that the readings were equivocal.
findings on lymphoscintigraphy were not as abnormal
as would be expected for an individual said to have such
long-standing disease. She does not fulfill the criteria for
affected status, but, in view of the uncertainty, we have
included her as being of unknown status. Individual
3.III.5 has no lymphedema on examination, but has, at
30 min, an abnormal lymphoscintigraphy result and a
normal result at 60 min. He has no other associated
features. In view of his lymphoscintigraphy result, we
have been cautious and have included him as being of
unknown status.
Some family members could not be assigned definite
status because a full clinical examination was not con-
ducted. In family 1, this was the case for individuals
1.II.3 and 1.III.3. In the former subject, an examination
was not possible, but details obtained from a telephone
conversation suggested that she was unaffected. Individ-
ual 1.III.3 had a cleft palate, and other family members
were convinced that he was affected; however, the pa-
tient refused to be examined. Neither patient was used
in the linkage analysis.
DNA was extracted from peripheral-venous-blood
samples by conventional methods. Polymorphic micro-
satellite markers, predominantly from the Ge´ne´thon set,
were PCR amplified and electrophoresed through 4.5%
denaturing polyacrylamide gels either on an ABI377
DNA sequencer or on a conventional gel rig. For PCR
products electrophoresed on the ABI377, one oligonu-
cleotide primer was end-labeled during synthesis with a
fluorescent tag, and the results were analyzed by use of
GENESCAN and GENOTYPER software. For conven-
tional PAGE, one PCR primer was end-labeled by T4
polynucleotide kinase and [32P]-ATP, and the gel was
exposed to autoradiography film for 1–16 hr.
The two-point and multipoint analyses were per-
formed by the MLINK suite of programs. The model
used was one in which disease alleles were given a fre-
quency of .0001, penetrance was set at 90%, and no
sporadic cases were allowed.
Results
Results of the clinical examinations are shown in ta-
bles 1 and 2, and pedigrees of the three families, in-
cluding haplotypes D16S511–D16S3074, are illustrated
in figure 1. The clinical data are provided in two tables
because only family 3 had lymphoscintigraphy.
The framework-genomewide search, which used 220
markers, yielded three areas—on chromosomes 2, 10,
and 16—with a total LOD score 11 obtained for the
three families. Analysis of further markers in the first
two regions showed that there was no cosegregation of
the same haplotype with the disease. Marker D16S514
gave an initial two-point LOD score of 5.4 at recom-
bination fragment (v) 0 (table 3), and, on typing addi-
tional markers, the maximum two-point LOD score ob-
tained in this region was 5.86 for D16S3037.
Three-point analysis for D16S3037 and D16S520 gave
Figure 1 Family 1 (A), family 2 (B), and family 3 (C), with haplotypes for the markers shown. Markers are shown in the order, on the
chromosome, predicted by use of the Ge´ne´thon map.
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Table 3
Two-Point LOD Scores for the Markers Shown on the Pedigrees
MARKER
LOD SCORE AT v a
0 .05 .1 .15 .2 .25 .3 .35 .4
D16S511 1.47 4.76 4.51 4.09 3.57 2.98 2.34 1.67 1.01
D16S422 .87 2.6 2.53 2.3 1.99 1.62 1.23 .84 .48
D16S402 4.61 4.32 3.94 3.5 3.01 2.48 1.93 1.36 .8
D16S3037 5.86 5.43 4.92 4.37 3.77 3.13 2.47 1.77 1.08
D16S520 5.4 4.98 4.48 3.95 3.37 2.76 2.13 1.5 .87
D16S3074 10.11 .59 1.16 1.32 1.29 1.15 .93 .68 .41




LOD Score at v a
0 .05 .1 .15 .2 .25 .3 .35 .4
1 1.16 1.05 .94 .82 .7 .57 .44 .32 .2
2 3.19 3.03 2.8 2.53 2.21 1.85 1.46 1.04 .6
3 1.84 1.66 1.47 1.28 1.08 .89 .69 .51 .33
Total 6.19 5.74 5.21 4.63 3.99 3.31 2.59 1.87 1.13
a LOD scores are for individual families and for all three families
combined. An unknown status is assumed for individual 3.III5 in fam-
ily 3 (see Discussion section).
a LOD score of 6.19 at (table 4). Recombinationv  0
events for D16S3074 and D16S422 place these markers
at the limits of the mapped area for the gene, which is
a distance of ∼16 cM according to the Ge´ne´thon LOD
3 map. Overall, all three families have findings that are
consistent with linkage to a locus on chromosome 16q.
Discussion
The difficulties encountered in linkage analysis of pri-
mary lymphedema (Hardy et al. 1995) led us, in this
study, to use LD in which the distichiasis provided a
clear phenotype by which to define affected status. The
establishment of linkage to chromosome 16q24.3 has
justified this approach, and analysis of linked markers
in a wider set of families with primary lymphedema is
now indicated. The two clinical signs in this condition
show quite different ages at onset; distichiasis is present
from birth, whereas the onset of lymphedema occurs in
puberty or later. Distichiasis is not the presence of a
second row of eyelashes from the tarsal plate but, rather,
is the development of hairs from the meibomian gland,
an organelle that normally has a sebaceous function.
This strongly suggests that the gene(s) responsible for
this condition is (are) concerned with development. It is
possible that there is more than one gene involved, since
there are families in which either distichiasis or lym-
phedema occurs in isolation (Temple and Collins 1994);
however, the condition may be due to a single gene with
variable expression and penetrance. At the density of
markers used in the present study, there are no obvious
similarities seen between the segregating haplotypes in
the three families.
There are no affected individuals in the three families
that carry a haplotype inconsistent with linkage. How-
ever, in family 3, there is one affected individual (3.IV.5)
who carries the full affected haplotype. She does not
fulfill any of the inclusion criteria, although she does
show marked venous insufficiency at the age of only 26
years. According to our criteria, this would be classified
as nonpenetrance, but, if future clinical studies show that
venous insufficiency is associated with LD, then it would
be considered to be reduced expression. In the same fam-
ily, there is one unassigned individual (3.III.5) who has
part of the haplotype and is of uncertain status, as de-
scribed in the Subjects and Methods section. He carries
the top four markers of the affected haplotype and shares
the lowest two with his unaffected brother (3.III.6). Even
though the lymphoscintigraphy results for individual
3.III.5 are normal at 60 min, it is not possible to use
this finding to define his status, since a very similar pic-
ture is seen for individual 3.IV.4, who is known to be
affected because she has distichiasis. Thus, we know that
the case of individual 3.III.5 refines the interval, but it
is impossible to say in which direction.
The pubertal onset of lymphedema is suggestive of a
hormonal effect acting on a pre-existing structural mal-
formation in the lymphatic vessels, which would explain
why there is a difference in the onsets of distichiasis and
lymphedema. It is of interest that follicular tumors may
show sebaceous differentiation (Lever 1997). There
would therefore seem to be a dual developmental path-
way for these glands, and the gene involved in LD may
well be involved with the determination of the correct
path. Although there are no strong candidate genes in
the interval, the N-proteinase for type 3 collagen and
the cell matrix–adhesion regulator are possible contend-
ers. It is conceivable that either of these proteins could
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play a role in lymphatic structure and, perhaps, in de-
velopment as well.
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